Alexion Pharmaceuticals' Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Alexion Pharmaceuticals careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Position Summary The role of the Global Market Research and Analytics Lead is to support Alexion global marketing teams by enabling high quality, evidence based decision making. This person will play a key role in mining critical insight...
Posted: May 14, 2019, 2:07 am
This position can be based in New Haven, CT or Boston, MA Position Summary The Sr. Manager, Quality - IT Supplier Management has an enterprise level focus within Quality ensuring consistent and timely control systems and proces...
Posted: May 12, 2019, 12:05 pm
Summary The Corporate and Business Development Finance team partners with the business to support external business development assessments and subsequent post-merger integration, as well as internal portfolio pipeline assessments, throug...
Posted: May 11, 2019, 3:15 am
Position Summary Senior Manager within OneSource Case Management will plan/coordinate and implement all on-boarding of new hires in conjunction with Medical counterparts to assure appropriate disease/treatment education to provide suppor...
Posted: May 11, 2019, 3:15 am
Summary The Corporate and Business Development Finance team partners with the business to support external business development assessments and subsequent post-merger integration, as well as internal portfolio pipeline assessments, throug...
Posted: May 11, 2019, 3:15 am

Viewing page 2 of 34|Previous Page|Next Page

  Newsfeed | Subscribe  

Apr 26, 2019 (Market Exclusive via COMTEX) -- Analyst Ratings For Alexion Pharmaceuticals, Inc. ALXN, -0.38% Today, Raymond James raised its price target on Alexion Pharmaceuticals, Inc. ALXN, -0.38% ...
Posted: April 26, 2019, 6:19 am
There was good news the last time Alexion Pharmaceuticals (NASDAQ:ALXN) reported its quarterly results. In February, the company announced higher revenue compared to the prior-year period. Adjusted ...
Posted: April 25, 2019, 11:37 am
BOSTON (AP) _ Alexion Pharmaceuticals Inc. (ALXN) on Thursday reported first-quarter net income of $587.9 million. On a per-share basis, the Boston-based company said it had profit of $2.61. Earnings, ...
Posted: April 25, 2019, 4:39 am
* SEES FY 2019 GAAP EPS IN RANGE $6.76 TO $7.96 * SEES FY 2019 NON-GAAP EPS IN RANGE $9.25 TO $9.45 * FY2019 EARNINGS PER SHARE VIEW $9.31, REVENUE VIEW $4.75 BILLION -- REFINITIV IBES DATA Source ...
Posted: April 25, 2019, 3:43 am

Viewing page 2 of 2|Previous Page